LIPPMAN MARC E enters ASCENTAGE PHARMA GROUP INTERNATIONAL with 21.17K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/19/2026ACC: 0001213900-26-031646
Director
Since Mar 2026
21.17K
Baseline shares
100% direct
21.17K
Direct ownership
1 position
117.79K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned21.17K
Total
21.17K direct21.17K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 21.17K | Direct |
| Total | 21.17K | 21.17K direct |
Derivative Holdings2
Options
DirectUnderlying security
Ordinary Shares
Underlying shares
53.90K
Shares owned
N/A
Exercise price
8.14
Expiration
—
Exercise window
—
Restricted stock units
DirectUnderlying security
Ordinary Shares
Underlying shares
63.90K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
117.79K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Ordinary Shares | 8.14 | — | — | 53.90K | N/A |
| Restricted stock units Direct | Ordinary Shares | 0 | — | — | 63.90K | N/A |
| Total | 117.79K | 0.00 | ||||